NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.
Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.
UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.
NCI, SAIC To Support Contracts For Molecular Target Labs.
NCAB: An Extraordinary Opportunity For Budgetary Coordination.
Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.
BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.
Aventis, MediGene In Pact For Development Of Vaccine.
Firm To Study Imaging System As Adjunct To Mammogram.
Techniclone Wins Patent For Tumor Necrosis Therapy.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Bhattacharya cancels NIH all-hands meeting
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - In the Headlines: “There’s no one to stand up for NCI right now.”
- George Weiner: Cancer centers are special, as are site visits in CCSG review
